Medical education provided by a clinical pharmacist

Impact on the use and cost of corticosteroid therapy in chronic obstructive pulmonary disease

Timothy Self, S. L. Smith, R. L. Boswell, W. A. Miller

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The impact of medical education provided by a clinical pharmacist on the use and cost of corticosteroid therapy in acute exacerbations of chronic obstructive pulmonary disease was evaluated. Three separate two-month audits of corticosteroid use were conducted on the pulmonary medicine service (PMS) of a teaching hospital. For the first audit period, no education was given and no clinical pharmacist was on the PMS. During the second audit period, no education was given, but a clinical pharmacist was on-service. For the third audit period, education (brief discussion and a handout) was given to new house staff members by the clinical pharmacist on the PMS. A significant reduction in the mean number of intravenous steroid doses, steroid cost per day, and patient steroid charges per day occurred in the third vs. the first period. Steroid cost per day and patient steroid charges per day were lower in the third period than the second, but the difference was not statistically significant.

Original languageEnglish (US)
Pages (from-to)241-244
Number of pages4
JournalDrug Intelligence and Clinical Pharmacy
Volume18
Issue number3
DOIs
StatePublished - Jan 1 1984

Fingerprint

Medical Education
Pharmacists
Chronic Obstructive Pulmonary Disease
Adrenal Cortex Hormones
Pulmonary Medicine
Steroids
Costs and Cost Analysis
Education
Therapeutics
Internship and Residency
Teaching Hospitals

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Medical education provided by a clinical pharmacist : Impact on the use and cost of corticosteroid therapy in chronic obstructive pulmonary disease. / Self, Timothy; Smith, S. L.; Boswell, R. L.; Miller, W. A.

In: Drug Intelligence and Clinical Pharmacy, Vol. 18, No. 3, 01.01.1984, p. 241-244.

Research output: Contribution to journalArticle

@article{9f786487fc0f4a5c8098a5697d2486a1,
title = "Medical education provided by a clinical pharmacist: Impact on the use and cost of corticosteroid therapy in chronic obstructive pulmonary disease",
abstract = "The impact of medical education provided by a clinical pharmacist on the use and cost of corticosteroid therapy in acute exacerbations of chronic obstructive pulmonary disease was evaluated. Three separate two-month audits of corticosteroid use were conducted on the pulmonary medicine service (PMS) of a teaching hospital. For the first audit period, no education was given and no clinical pharmacist was on the PMS. During the second audit period, no education was given, but a clinical pharmacist was on-service. For the third audit period, education (brief discussion and a handout) was given to new house staff members by the clinical pharmacist on the PMS. A significant reduction in the mean number of intravenous steroid doses, steroid cost per day, and patient steroid charges per day occurred in the third vs. the first period. Steroid cost per day and patient steroid charges per day were lower in the third period than the second, but the difference was not statistically significant.",
author = "Timothy Self and Smith, {S. L.} and Boswell, {R. L.} and Miller, {W. A.}",
year = "1984",
month = "1",
day = "1",
doi = "10.1177/106002808401800313",
language = "English (US)",
volume = "18",
pages = "241--244",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "3",

}

TY - JOUR

T1 - Medical education provided by a clinical pharmacist

T2 - Impact on the use and cost of corticosteroid therapy in chronic obstructive pulmonary disease

AU - Self, Timothy

AU - Smith, S. L.

AU - Boswell, R. L.

AU - Miller, W. A.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - The impact of medical education provided by a clinical pharmacist on the use and cost of corticosteroid therapy in acute exacerbations of chronic obstructive pulmonary disease was evaluated. Three separate two-month audits of corticosteroid use were conducted on the pulmonary medicine service (PMS) of a teaching hospital. For the first audit period, no education was given and no clinical pharmacist was on the PMS. During the second audit period, no education was given, but a clinical pharmacist was on-service. For the third audit period, education (brief discussion and a handout) was given to new house staff members by the clinical pharmacist on the PMS. A significant reduction in the mean number of intravenous steroid doses, steroid cost per day, and patient steroid charges per day occurred in the third vs. the first period. Steroid cost per day and patient steroid charges per day were lower in the third period than the second, but the difference was not statistically significant.

AB - The impact of medical education provided by a clinical pharmacist on the use and cost of corticosteroid therapy in acute exacerbations of chronic obstructive pulmonary disease was evaluated. Three separate two-month audits of corticosteroid use were conducted on the pulmonary medicine service (PMS) of a teaching hospital. For the first audit period, no education was given and no clinical pharmacist was on the PMS. During the second audit period, no education was given, but a clinical pharmacist was on-service. For the third audit period, education (brief discussion and a handout) was given to new house staff members by the clinical pharmacist on the PMS. A significant reduction in the mean number of intravenous steroid doses, steroid cost per day, and patient steroid charges per day occurred in the third vs. the first period. Steroid cost per day and patient steroid charges per day were lower in the third period than the second, but the difference was not statistically significant.

UR - http://www.scopus.com/inward/record.url?scp=0021350067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021350067&partnerID=8YFLogxK

U2 - 10.1177/106002808401800313

DO - 10.1177/106002808401800313

M3 - Article

VL - 18

SP - 241

EP - 244

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 3

ER -